Management of Heart Block in Children

Diagnosis and Monitoring

Children with suspected Mobitz type 1 AV block should undergo complete 12-lead ECG to assess QRS morphology and duration, and 24-48 hour Holter monitor to determine frequency and duration of AV block episodes, minimum heart rate during block episodes, and correlation with symptoms (if any), as recommended by the American Heart Association 1
Annual 24-hour Holter monitoring and clinical evaluation for symptoms such as syncope, dizziness, and exercise intolerance are recommended for children with Mobitz type 1 heart block, according to the American College of Cardiology 2
Development of complete heart block is a significant concern in children with Mobitz type 1 heart block, with research showing that evidence of progression to Mobitz type II or high-grade AV block is a critical factor in management 2

Medication awareness is crucial, as negative chronotropic medications (beta-blockers, calcium channel blockers, digoxin) may worsen conduction in children with Mobitz type 1 heart block 2
Parents and patients should be educated about symptoms that warrant urgent evaluation, such as syncope, pre-syncope, and significant exercise intolerance, as recommended by the American Academy of Pediatrics 2
Asymptomatic children with isolated Mobitz type 1 block can participate in normal activities and sports if they have an appropriate heart rate response to exercise, according to the American Heart Association 2

Approximately 30% of children with concerning second-degree block may progress to complete heart block or require pacemaker over long-term follow-up, highlighting the importance of regular monitoring and follow-up 1
The combination of first-degree AV block and non-specific intraventricular block is associated with increased risk of progression to complete heart block, especially when accompanied by symptoms, as stated by the American College of Cardiology 3
Permanent pacing is recommended (Class I) for patients with evidence of alternating bundle branch block, as this represents extensive conduction system disease with high risk of progression, according to the American College of Cardiology 3

A 12-lead ECG should be performed to confirm the diagnosis and assess QRS morphology and duration in patients with suspected conduction system disease 4
Ambulatory ECG monitoring is recommended to detect intermittent higher-degree AV block in patients with first-degree AV block and non-specific intraventricular block, as recommended by the American College of Cardiology 4
Exercise testing should be performed if exertional symptoms are present to determine if the PR interval fails to adapt appropriately with exercise, according to the American College of Cardiology 4
Electrophysiologic study (EPS) may be considered to determine the level of block and risk of progression in patients with conduction system disease, as suggested by the American College of Cardiology 4

Dual-chamber pacing (DDD) is recommended to maintain AV synchrony in patients with preserved left ventricular ejection fraction (>50%) who require permanent pacing, as recommended by the American College of Cardiology and Circulation guidelines 5
Physiologic pacing methods (cardiac resynchronization therapy or His bundle pacing) should be considered over right ventricular pacing in patients with reduced left ventricular ejection fraction (36-50%) and expected ventricular pacing >40%, according to the American College of Cardiology and Circulation guidelines 5
Permanent pacing is recommended for patients with acquired second-degree Mobitz type II atrioventricular block, high-grade atrioventricular block, or third-degree atrioventricular block not attributable to reversible causes, regardless of symptoms, as recommended by the American College of Cardiology 4, 5

Regular ECG monitoring (every 6-12 months) is recommended for patients not receiving a pacemaker, along with prompt evaluation for any new or worsening symptoms and patient education regarding symptoms of bradycardia or heart block 3
Assessing hemodynamic stability and symptoms is crucial; if unstable, administer atropine 0.5 mg IV (may repeat to maximum 2.0 mg) for symptomatic bradycardia, and consider beta-adrenergic agonists if no response to atropine and low likelihood of coronary ischemia, as recommended by the American College of Cardiology 4, 6
Reversible causes of AV block should be treated first, and permanent pacing should not be performed if the block resolves with treatment, emphasizing the importance of identifying and addressing underlying causes, as recommended by the American College of Cardiology and the American Heart Association 5, 4